CHU Nantes - Hopital Hotel Dieu Service Hematologie

Nantes 44000

0 studies enrolling now · 1 studies all time

What they study most

Disease, Hodgkin

Studies at this site

• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed